NEUROACTIVE STEROID FORMULATIONS AND METHODS OF TREATING CNS DISORDERS
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
N/A
Issued Date -
N/A
app pub date -
Jan 23, 2013
filing date -
Jan 23, 2012
priority date (Note) -
Abandoned
status (Latency Note)
Importance
Calculated Rating
|
US Family Size
|
Non-US Coverage
|
Abstract
Formulations of comprising a neuroactive steroid, e.g., allopregnanolone; and optionally a cyclodextrin, e.g., a β-cyclodextrin, e.g., a sulfo butyl ether β-cyclodextrin, e.g., a β-cyclodextrin, e.g., a sulfo butyl ether β-cyclodextrin, e.g., CAPTISOL®; and methods of use in treating CNS disorders.
First Claim
Other Claims data not available
Family
+
−
| Country | kind | publication No. | Filing Date |
|---|---|---|---|
| BR | B1 | BR112014018110 | Jan 23, 2013 |
| EP | A2 | EP4295908 | Jan 23, 2013 |
| AU | B2 | AU2013212287 | Jan 23, 2013 |
| CN | A | CN112472814 | Jan 23, 2013 |
| EP | A1 | EP3650027 | Jan 23, 2013 |
| CA | C | CA2862076 | Jan 23, 2013 |
| CN | A | CN104736158 | Jan 23, 2013 |
| EP | B1 | EP2806877 | Jan 23, 2013 |
| AU | B2 | AU2018201307 | Feb 22, 2018 |
| AU | B2 | AU2020217402 | Aug 13, 2020 |
International Classification(s)
- 2013 Application Filing Year
- A61K Class
- 12711 Applications Filed
- 11051 Patents Issued To-Date
- 86.95 % Issued To-Date
Cited Art Landscape
Patent Citation Ranking
- 30 Citation Count
- A61K Class
- 95.83 % this patent is cited more than
- 10 Age